Optimum Investment Advisors’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-160
Closed -$3K 857
2022
Q3
$3K Hold
160
﹤0.01% 715
2022
Q2
$3K Hold
160
﹤0.01% 747
2022
Q1
$3K Hold
160
﹤0.01% 780
2021
Q4
$3K Hold
160
﹤0.01% 772
2021
Q3
$3K Hold
160
﹤0.01% 789
2021
Q2
$4K Hold
160
﹤0.01% 840
2021
Q1
$5K Hold
160
﹤0.01% 829
2020
Q4
$5K Hold
160
﹤0.01% 791
2020
Q3
$4K Hold
160
﹤0.01% 790
2020
Q2
$3K Hold
160
﹤0.01% 803
2020
Q1
$1K Hold
160
﹤0.01% 857
2019
Q4
$2K Hold
160
﹤0.01% 905
2019
Q3
$2K Hold
160
﹤0.01% 948
2019
Q2
$4K Sell
160
-160
-50% -$4.61K ﹤0.01% 872
2019
Q1
$10K Buy
+320
New +$11.4K ﹤0.01% 816

Other funds holding CVET

Optimum Investment Advisors's CVET Position: Q4 2022 in Review

Optimum Investment Advisors sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 160 shares — an estimated $3K sold.

Optimum Investment Advisors first reported a position in CVET in Q1 2019 and held it in 15 quarters. The position peaked at $10K in Q1 2019. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

  • Optimum Investment Advisors reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Optimum Investment Advisors sold 160 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $3K.
  • Optimum Investment Advisors first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 15 quarters.
  • Optimum Investment Advisors's Covetrus, Inc. Common Stock position peaked at $10K in Q1 2019.
  • 5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on Optimum Investment Advisors's 13F filing for Q4 2022, filed 5 Jan 2023.